The effect of glucosamine sulphate on osteoarthritis: design of a long-term randomised clinical trial [ISRCTN54513166]

BACKGROUND: Pharmacological treatment for osteoarthritis (OA) can be divided into two groups: symptom-modifying drugs and disease-modifying drugs. Symptom-modifying drugs are currently the prescription of choice for patients with OA, as disease-modifying drugs are not yet available in usual care. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozendaal, Rianne M, Koes, Bart W, Weinans, Harrie, Uitterlinden, Elian J, van Osch, Gerjo JVM, Ginai, Abida Z, Verhaar, Jan AN, Bierma-Zeinstra, Sita MA
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090586/
https://www.ncbi.nlm.nih.gov/pubmed/15850497
http://dx.doi.org/10.1186/1471-2474-6-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090586/
https://www.ncbi.nlm.nih.gov/pubmed/15850497
http://dx.doi.org/10.1186/1471-2474-6-20

Ejemplares similares